[1] Jemal A, Siegel R, Samuels A, Ward E, Hao YP Xu JQ, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin, 2008, 58(1): 71–96.

[2] Liu GF. Epidemiologieal survey of benign prostatic hy-perplasia and prostate cancer in China. Chin Med J, 2000, 113(4): 299–302.

[3] Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang SM, Ozen M, Pathak S, Chung LWK. LNCaP Progression model of human prostate cancer: androgen-independence and osseous metastasis. Prostate, 2000, 44(2): 91–103.

[4] Volmer MW, Radacz Y, Hahn SA, Klein-Scory S, Stuhler K, Zapatka M, Schmiegel W, Meyer HE, Schwarte- Waldhoff I. Tumor suppressor Smad4 mediates downregulation of the anti-adhesive invasion promoting matricellular protein SPARC: Landscaping activity of Smad4 as revealed by a “se-cretome” analysis. Proteomics, 2004, 4(5): 1324–1334.

[5] 甄朱. 蛋白质组学进展. 生物工程学报, 2001, 17(5): 491–493.

[6] 吴松锋, 朱云平, 贺福初. 人类蛋白质组表达谱蛋白质鉴定的分步搜索策略. 遗传, 2005, 27(5): 687–693.

[7] Sardana G, Marshall J, Diamandis EP. Discovery of can-didate tumor markers for prostate cancer via proteomic analysis of cell culture-conditioned medium. Clin Chem, 2007, 53(3): 429–437.

[8] Martin DB, Gifford DR, Wright ME, Keller A, Yi E, Goodlett DR, Aebersold R, Nelson PS. Quantitative pro-teomic analysis of proteins released by neoplastic prostate epithelium. Cancer Res, 2004, 64(1): 347–355.

[9] Katayama M, Nakano H, Ishiuchi A, Wu WW, Oshima R, Sakurai J, Nishikawa H, Yamaguchi S, Otsubo T. Protein pattern difference in the colon cancer cell lines examined by two-dimensional differential in-gel electrophoresis and mass spectrometry. Surg Today, 2006, 36(12): 1085–1093.

[10] Chen GA, Gharib TG, Huang CC, Thomas DG, Shedden KA, Taylor JMG, Kardia SLR, Misek DE, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG. Pro-teomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin Cancer Res, 2002, 8(7): 2298–2305.

[11] Li C, Xiao ZQ, Chen ZC, Zhang XP, Li JL, Wu XY, Li XY, Yu H, Li MY, Zhu G, Liang SP. Proteome analysis of human lung squamous carcinoma. Proteomics, 2006, 6(2): 547–558.

[12] Montgomerie JZ, Gracy RW, Holshuh HJ, Keyser AJ, Bennett CJ, Schick DG. The 28K protein in urinary blad-der, squamous metaplasia and urine is triosephosphate isomerase. Clin Biochem, 1997, 30(8): 613–618.

[13] Grootjans JJ, Zimmermann P, Reekmans G, Smets A, De-geest G, Durr J, David G. Syntenin, a PDZ protein that binds syndecan cytoplasmic domains. Proc Natl Acad Sci USA, 1997, 94(25): 13683–13688.

[14] Luyten A, Mortier E, Van Campenhout C, Taelman V, De-geest G, Wuytens G, Lambaerts K, David G, Bellefroid EJ, Zimmermann P. The postsynaptic density 95/disc-large/zona occludens protein syntenin directly interacts with frizzled 7 and supports noncanonical Wnt signaling. Mol Biol Cell, 2008, 19(4): 1594–1604.

[15] Boukerche H, Su ZZ, Prevot C, Sarkar D, Fisher PB. mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src. Proc Natl Acad Sci USA, 2008, 105(41): 15914–15919.